Dahlgren, D.; Cano-Cebrián, M.-J.; Olander, T.; Hedeland, M.; Sjöblom, M.; Lennernäs, H.
Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat. Pharmaceutics 2020, 12, 242.
https://doi.org/10.3390/pharmaceutics12030242
AMA Style
Dahlgren D, Cano-Cebrián M-J, Olander T, Hedeland M, Sjöblom M, Lennernäs H.
Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat. Pharmaceutics. 2020; 12(3):242.
https://doi.org/10.3390/pharmaceutics12030242
Chicago/Turabian Style
Dahlgren, David, Maria-Jose Cano-Cebrián, Tobias Olander, Mikael Hedeland, Markus Sjöblom, and Hans Lennernäs.
2020. "Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat" Pharmaceutics 12, no. 3: 242.
https://doi.org/10.3390/pharmaceutics12030242
APA Style
Dahlgren, D., Cano-Cebrián, M.-J., Olander, T., Hedeland, M., Sjöblom, M., & Lennernäs, H.
(2020). Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat. Pharmaceutics, 12(3), 242.
https://doi.org/10.3390/pharmaceutics12030242